SCHEMBL4660190

SCHEMBL4660190

CC(C)(C)OC(=O)C(C)(C#N)C(c1ccccc1OC(F)(F)F)c1cccc2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.48
ESR2 Q92731 1/20 0.48
ALDH1A1 P00352 2/20 0.38
HSD17B10 Q99714 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
KCNK3 O14649 2/20 0.35
KCNK9 Q9NPC2 2/20 0.35
SLC22A12 Q96S37 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HDAC3 O15379 1/20 0.32
CYP2C9 P11712 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
F2R P25116 1/20 0.32
PPARG P37231 1/20 0.31
PPARD Q03181 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4662659 0.89 ESR1 (0.53) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL4661489 0.89 ESR1 (0.53) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL4660011 0.88 ESR1 (0.50) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL4661576 0.85 ESR1 (0.45) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL4661381 0.84 ESR1 (0.41) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL4660073 0.84 ESR1 (0.41) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL4661552 0.81 ESR1 (0.39) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL13938655 0.80 ESR1 (0.54) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL4135203 0.80 ESR1 (0.54) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL4660064 0.77 KDM4E (0.38) ESR1ESR2ALDH1A1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620102-B1 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS WYETH CORP (US) 2008-12-24 EP claimed
US-20070299105-A1 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use WYETH (US) 2007-12-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299105-A1 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use HCAR2, PCCA, MCCC2 ESR1 4478/4885ESR2 1808/4885ALDH1A1 1159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.